Mechanisms of immune injury in multiple sclerosis

Brain Pathology

Volumn 6, Issue 3, 1996, Pages 243-257

  Brosnan, Celia F ^a   Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; DEMYELINATING DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NONHUMAN; RABBIT; RAT; T LYMPHOCYTE SUBPOPULATION; TISSUE INJURY; ULTRASTRUCTURE;

EID: 0030056639     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00853.x     Document Type: Conference Paper

References (100)

1. Barten DM, Ruddle NH (1994) Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis J Neuroimmunol 51. 123-33
2. Battistini L, Fischer FR, Raine CS, Brosnan CF (1996) CD1b is expressed in multiple sclerosis lesions. J Neuroimmunol in press
3. Battistini L, Salvetti M, Ristori G, Falcone M, Raine CS, Brosnan CF (1995) γδ cell receptor analysis supports a role for HSP 70 selection of lymphocytes in multiple sclerosis lesions Mol Med 1 554-62
4. Bendelac A (1995) CD1: presenting unusual antigens to unusual T lymphocytes. Science 269. 185-6
5. Berman JW, Guida MP, Warren J, Brosnan CF (1996) Localization of MCP-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat J. Immunol 156 3017-23
6. Billiau A (1995) Interferons in multiple sclerosis: warning from experiences Neurology 45: S50-3
7. Bliss J, van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF (1996) IL-12, as an adjuvant, promotes a Th1 cell, but does not suppress a Th2 recall response. J Immunol 156: 887-94
8. Bo L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD (1994) Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51: 135-46
9. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-86
10. Brosnan CF, Battistini L, Gao Y-L, Raine CS, Aquino DA. (1996) Heat shock proteins and multiple sclerosis. J Neuropath Exp Neurol 55: 389-402
11. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC (1994) Reactive nitrogen intermediates in human neurpathology: an overview. Devl Neurosci 16: 152-61
12. Brosnan CF, Bloom BR, Bornstein MB (1981) The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126: 614-620
13. Brosnan CF, Cannella B, Battistini L, Raine CS (1995) Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45: S16-S21
14. Brosnan CF, Stoner GL, Bloom BR, Wisniewski HM. (1977) Studies on demyelination by activated lymphocytes in the rabbit eye. II Antibody-dependent cell-mediated demyelination. J Immunol 118: 2103-2110
15. Brunner M, Larsen S, Sette A, Mitchison A (1995) Altered Th1/Th2 balance associated with the immuno-suppressive/protective effect of the H-2Ab allele on immunosuppressive/protective effect of the H-2b allele on the response to allo-4-hydroxyphenylpyruvate dioxygenase. Eur J Immunol 25. 3285-3289
16. Cannella B, Cross AH, Raine CS (1990) Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 172: 1521-1524
17. Cannella B, Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37: 424-435
18. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240
19. Compston DAS (1993) Inflammation and the brain. Mol Chem Neuropath 19: 47-64
20. Compston DAS, Morgan BP, Campbell AK (1987) Cerebrospinal fluid complement components in multiple sclerosis. In Cellular and Humoral Immunological Components of Cerebrospinal Fluid in Multiple Sclerosis. A Lowenthal, J Raus, (eds). pp201-9, Plenum Press: New York
21. Compston DAS, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, Jasani B (1989) Immunocytochemical localization of the terminal complement complex in multiple sclerosis Neuropath Appl Neurobiol 15. 307-16
22. Cross AH, Cannella B, Brosnan CF, Raine CS (1991) Hypothesis: antigen-specific T cells prime CNS endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination J Neuroimmunol 33: 237-244
23. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93: 2684-90
24. Cuff CA, Martiney JA, Berman JW, Brosnan CF. (1996) Transforming growth factor β1 down-modulates IL-1β-induced cellular inflammation in the rabbit retina but does not increase edema and by itself causes alterations in vascular permeability. J Neuroimmunol in press
25. Epstein LG, Prineas JW, Raine CS (1983) Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis J Neurol Sci 61: 341-8
26. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272: 50-54
27. Freedman MS, Ruijs TCG, Selin LK, Antel JP (1991) Peripheral blood γδ T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol 30: 794-7
28. Gehrmann J, Matsumoto Y, Kreutzberg GW (1995) Microglia: intrinsic immune effector cell of the brain. Brain Res Rev 20: 269-87
29. Gijbels K, Brocke S, Abrams JS, Steinman L (1995) Antibodies to IL-6 reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol Med 1: 795-805
30. Gijbels K, Galardy RE, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin invest 94: 2177-82
31. Glabinski AR, Tani M, Aras S, Stoler MH, Tuohy VK, Ransohoff RM (1995) Regulation and function of central nervous system chemokines. [Review] Int J Dev Neurosc 13: 153-65
32. Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39: 625-35
33. Hafler DA, Weiner HL (1995) Immunological mechanisms and therapy in multiple sclerosis (Review) Immunol Rev 144: 75-107
34. Hahn S, Gehri R, Erb P (1995) Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 146: 57-79
35. Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV (1992) The inflammatory mediators in demyelinating disorders of the CNS and PNS. (Review) J. Neuroimmunol 40. 197-210
36. + T cells isolated from different mouse strains J Immunol 155: 3788-93
37. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607-12
38. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merrill JE (1986) Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain J Immunol 136: 3239-45
39. Huitinga I, van Rooijen N, deGroot CJA, Uitdehaag BMJ, Dijkstra CD (1990) Elimination of macrophages infiltrating the CNS suppresses EAE in rats. J Exp Med 172: 1025-33
40. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK (1991) Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J Immunol 146: 2983-2989
41. + T cells in murine experimental allergic encephalomyelitis Science 256: 1213-5
42. Johns LD, Flanders KC, Ranges GE, Sriram S (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 147: 1792-6
43. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD (1995) An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155: 5003-10
44. Kaufmann SH (1996) γδand other unconventioanl T lymphocytes. what do they see and what do they do? Proc Natl Acad Sci (USA) 93: 2272-9
45. Koh DR, Fung-Leung WP, Ho A, Gray D, Acha-Orbea H, Mak TW (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. Science 256: 1210-3
46. Kuruvilla AP, Sah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ (1991). Protective effect of transforming growth factor-β1 on experimental diseases in mice. Proc Natl Acad Sci (USA) 88: 2918-21
47. Lee SC, Dickson DW, Brosnan CF (1995) Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav Imm 9: 345-54
48. Linington C, Engelhardt B, Kapocs G, Lassmann H (1992) Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol 40, 219-24
49. Mannie MD, Dinarello CA, Paterson PY (1987) Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats J Immunol 138: 4229-4235
50. Martin R, McFarland HF (1996) Immunology of Multiple Sclerosis. In Multiple Sclerosis, Raine CS, MacFarland H, Tourtellotte W. (eds), Chapman and Hall: Texas.
51. Massacesi L, Castigli E, Vergelli M, Olivotto J, Abbamondi AL, Sarlo F, Amaducci L (1991). Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J Clin Invest 88: 1331-7
52. McDonald H Robson (1995) NK1.1+ T cell receptor-α/β+ cells new clues to their origin, specificity and function. J Exp Med 182: 633-7
53. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 15: 2132-2141
54. Miller SD, Karpus WJ (1994) The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 15. 356-61
55. Mobner R, Fassbender K, Kuhnen J, Schwartz A, Hennerici M (1996) Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques. J Neuroimmunol 65: 61-5
56. Moore GR, Raine CS (1988) Immunogold localization and analysis of IgG during immune-mediated demyelination Lab Invest 59: 641-8
57. Mosmann TR, Coffman RL (1989). TH1 and TH2 cells Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7: 145-73
58. Nicoletti F, Patti F, Cocuzza C, Zaccone P, Nicoletti A, Di Marco R, Reggio A. (1996) Elevated levels of serum IL-12 in chronic-progressive multiple sclerosis. J Neuroimmunol in press
59. Olsson T (1995) Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis (Review) Immunol Rev 144: 245-68
60. Panitch HS, Bever CT Jr (1993) Clinical trials of interferons in multiple sclerosis What have we learned? [Review] J Neuroimmunol 46: 155-64
61. Prineas JW, Graham JS (1981) Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 10: 149-58
62. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad. Sci (USA) 92: 11294-8
63. Racke M K, Burnett, D, Pak S-H, Albert P S, Cannella B, Raine CS, McFarlin DE, Scott DE (1995). Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J Immunol 154: 450-8
64. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A., Raine CS, Shevach EM, Rocken M (1994). Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180. 1961-6
65. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146: 3012-7
66. Raine CS (1990) Demyelinating diseases. In Textbook of Neuropathology, 2nd edition, pp 535-620. Davis RL and Roberstson (eds), Williams and Wilkins: Baltimore
67. Raine CS (1985) Experimental allergic encephalomyelitis and experimental allergic neuritis. In Handbook of Clinical Neurology, Vinken PJ, Bruyn GW and Klawans HL (eds), vol 3: 429-466. Elsevir Amsterdam.
68. Raine CS (1994) The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 36: S61-S72
69. Raine CS, Bornstein MB (1970) Experimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro. J Neuropathol Exp Neurol. 29: 177-91
70. Rajan A, Gao Y-L, Raine CS, Brosnan CF (1996) A pathogenic role for γδ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J Immunology, in press.
71. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592-600
72. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A, Poser S (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity Ann Neurol 37. 82-8
73. Rieckmann P, Martin S, Weichseibraun I, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A, Poser S (1994) Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: clCAM-1 is an indicator for relapse Neurology. 44: 2367-72
74. Rinner WA, Bauer J, Schmidts M, Lassmann H, Hickey WF (1995) Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras Glia 14: 257-66
75. Romagnani S (1995) Biology of human Th1 and Th2 cells (Review). J Clin Immunol 15: 121-9
76. Ruddle NH, Bergaman CM, McGrath ML, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172: 1193-1200.
77. Selmaj KW (1992) The role of cytokines in inflammatory conditions of the central nervous system. Sem Neurosci 4: 22-7
78. Selmaj KW, Raine CS, Cannella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949-954
79. Selmaj KW, Brosnan CF, Raine CS (1991) Colocalization of lymphocytes bearing the γδ T cell receptor and heat shock protein 65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci (USA) 88: 6452-6
80. Selmaj KW, Brosnan CF, Raine CS (1992) Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro. implications for multiple sclerosis. Neurology 42: 795-800
81. Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-46
82. Selmaj KW, Raine CS, Cross AH (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol 30: 694-700
83. Sobel RA, Mitchell, ME (1989) Fibronectin in multiple sclerosis lesions. Am J Pathol 135: 161-8
84. Sobel RA, Chen M, Maeda A, Hinojoza JR (1995) Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions J Neuropathol Exp Neurol 54: 202-13
85. Sobel RA, Mitchell ME, Fondren G (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136: 1309-16
86. Steinman L (1996) A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells A tale of smart bombs and infantry [Review]. Proc Natl Acad Sci (USA) 93: 2253-2256
87. + T cell responses to human myelin. Proc Natl Acad Sci (USA) 91: 10859-63
88. Ulvestad E, Williams K, Bo L, Trapp B, Antel JP, Mork S (1994b) HLA class II molecules (HLA-DR, DP, DQ) on cells in the human CNS studied in situ and in vitro. Immunol 82: 535-41
89. Ulvestad E, Williams K, Vedler C, Antel JP, Nyland H, Morke S, Matre R (1994) Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J Neurol Sci 121. 125-131
90. van Noort JM, van Sechel AC, Bajramovic JJ, el Ouagmiri M, Polman CH Lassmann H, Ravid R (1995) The small heat shock protein alpha-B crystallin as a candidate autoantigen in multiple sclerosis. Nature 375: 798-801
91. Warren KG, Catz I, Johnson E, Mielke B (1994) Antimyelin basic protein and anti-lipid proteolipid protein specific forms of multiple sclerosis. Ann Neurol 36: 89-97
92. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C (1994) Animal models (Review) Ann Neurol 36: 547-53
93. Williams K, Ulvestad E, Waage A, Antel J P, McLaurin J (1994d). Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res 38:433-433
94. Williams KC, Ulvestad E, Mickey WF (1994) Immunology of multiple sclerosis. Clin Neurosc 2: 229-245
95. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA (1995) Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions J Exp Med 182: 1985-96
96. Woodroofe MN (1995) Cytokine production in the central nervous system. Neurology 45: S6-S10
97. Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML, (1986) Immunocytochemical characterisation of the immune reaction in the nervous system in multiple sclerosis. Possible role for microglia in lesion J Neurol Sci 74: 135-52
98. Woodroofe MN, Cuzner ML (1993) Cytokine mRNA expression in inflammatory (MS) lesions: detection by non-radioactive in situ hybridization. Cytokine 5: 583-8
99. + T cells [Review]. Immunol Rev 146: 223-39
100. Yoshimoto T, Bendelac A, Hu-Li J, Paul WE (1995) Defective IgE production by SJL mice is linked to the absence of CD4+, NK1 1+ T cells that promptly produce IL-4. Proc Natl Acad Sci (USA) 92: 11931-4